{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:18:01Z","timestamp":1793085481435,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009409","name":"Russian Science Support Foundation","doi-asserted-by":"publisher","award":["14-15-00947 2014"],"award-info":[{"award-number":["14-15-00947 2014"]}],"id":[{"id":"10.13039\/100009409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10157-018-1591-1","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T02:52:19Z","timestamp":1528685539000},"page":"1351-1359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Effect of essential amino acid \u043aetoanalogues and protein restriction diet on morphogenetic proteins (FGF-23 and \u041alotho) in 3b\u20134 stages chronic \u043aidney disease patients: a randomized pilot study"],"prefix":"10.1007","volume":"22","author":[{"given":"Lyudmila","family":"Milovanova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Fomin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Moiseev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Taranova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury","family":"Milovanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Lysenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliy","family":"Kozlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kozevnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Milovanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Lebedeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Reshetnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"key":"1591_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"A Levin","year":"2013","unstructured":"Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, De Jong PE, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1\u2013150.","journal-title":"Kidney Int Suppl"},{"key":"1591_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/ki.2009.188","volume":"76","author":"K-U Eckardt","year":"2009","unstructured":"Eckardt K-U, Kasiske BL, et al. KDIGO clinical practice guideline for the diagnosis, evolution, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Elsevier. 2009;76:S1\u2013130.","journal-title":"Kidney Int Elsevier"},{"key":"1591_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12882-015-0214-2","volume":"17","author":"GB Piccoli","year":"2016","unstructured":"Piccoli GB, Capizzi I, Vigotti FN, Leone F, D\u2019Alessandro C, Giuffrida D, et al. Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines? BMC Nephrol. 2016;17:1\u201313.","journal-title":"BMC Nephrol"},{"issue":"5","key":"1591_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3390\/nu9050495","volume":"9","author":"J Rysz","year":"2017","unstructured":"Rysz J, Franczyk B, Cia\u0142kowska-Rysz A, Gluba-Brz\u00f3zka A. The effect of diet on the survival of patients with chronic kidney disease. Nutrients. 2017;9(5):495. \n                    https:\/\/doi.org\/10.3390\/nu9050495\n                    \n                  . ,.","journal-title":"Nutrients"},{"issue":"3","key":"1591_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/nu9030265","volume":"9","author":"M Snelson","year":"2017","unstructured":"Snelson M, Clarke RE, Coughlan MT. Stirring the pot: can dietary modification alleviate the burden of CKD? Nutrients. 2017; 9(3): 265. \n                    https:\/\/doi.org\/10.3390\/nu9030265\n                    \n                  .","journal-title":"Nutrients"},{"issue":"3","key":"1591_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/sj.ki.5001955","volume":"71","author":"BV Iorio Di","year":"2007","unstructured":"Di Iorio BV, De Nicola BR, Minutolo L, Zamboli R, Trucillo P. et al. Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney Int. 2007;71(3):245\u201351. \n                    https:\/\/doi.org\/10.1038\/sj.ki.5001955\n                    \n                  .","journal-title":"Kidney Int"},{"issue":"3","key":"1591_CR7","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/nu9030208","volume":"9","author":"Y Zha","year":"2017","unstructured":"Zha Y, Qian Q. Protein nutrition and malnutrition in CKD and ESRD. Nutrients. 2017;9(3):208. \n                    https:\/\/doi.org\/10.3390\/nu9030208\n                    \n                  .","journal-title":"Nutrients"},{"key":"1591_CR8","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Guti\u00e9rrez","year":"2008","unstructured":"Guti\u00e9rrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359:584\u201392.","journal-title":"N Engl J Med"},{"key":"1591_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1681\/ASN.2009121311","volume":"22","author":"MC Hu","year":"2011","unstructured":"Hu MC, Shi M, Zhang J, Qui\u00f1ones H, Griffith C, Kuro-o M, et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol Am Soc Nephrol. 2011;22:124\u201336.\n                    https:\/\/doi.org\/10.1681\/ASN.2009121311\n                    \n                  .","journal-title":"J Am Soc Nephrol Am Soc Nephrol"},{"key":"1591_CR10","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2215\/CJN.07870713","volume":"9","author":"S Seiler","year":"2014","unstructured":"Seiler S, Rogacev KS, Roth HJ, Shafein P, Emrich I, Neuhaus S, et al. Associations of FGF-23 and sklotho with cardiovascular outcomes among patients with CKD stages 2\u20134. Clin J Am Soc Nephrol. 2014;9:1049\u201358. \n                    https:\/\/doi.org\/10.2215\/CJN.07870713\n                    \n                  .","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"1591_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1152\/ajprenal.00199.2012","volume":"303","author":"NS Krieger","year":"2012","unstructured":"Krieger NS, Culbertson CD, Kyker-Snowman K, Bushinsky DA. Metabolic acidosis increases fibroblast growth factor 23 in neonatal mouse bone. Am J Physiol Renal Physiol. 2012;303(3):431\u20136. \n                    https:\/\/doi.org\/10.1152\/ajprenal.00199.2012\n                    \n                  .","journal-title":"Am J Physiol Renal Physiol"},{"key":"1591_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fendo.2017.00323","volume":"8","author":"GD Dalton","year":"2017","unstructured":"Dalton GD, Xie J, An S-W, Huang C-L. New insights into the mechanism of action of soluble klotho. Front Endocrinol (Lausann). 2017;8:323. \n                    https:\/\/doi.org\/10.3389\/fendo.2017.00323\n                    \n                  .","journal-title":"Front Endocrinol (Lausann)"},{"issue":"4","key":"1591_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.14283\/jfa.2013.26","volume":"2","author":"B Bartali","year":"2013","unstructured":"Bartali B, Semba RD, Araujo AB. Klotho, FGF21 and FGF23: novel pathways to musculoskeletal health? J Frailty Aging. 2013;2(4):179\u201383. \n                    https:\/\/doi.org\/10.14283\/jfa.2013.26\n                    \n                  .","journal-title":"J Frailty Aging"},{"key":"1591_CR14","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ki.2010.194","volume":"78","author":"MI Yilmaz","year":"2010","unstructured":"Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E, et al. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int. 2010;78:679\u201385. \n                    https:\/\/doi.org\/10.1038\/ki.2010.194\n                    \n                  .","journal-title":"Kidney Int"},{"key":"1591_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000452880","volume":"17","author":"X Lu","year":"2016","unstructured":"Lu X, Hu MC. Klotho\/FGF23 axis in chronic kidney disease and cardiovascular disease. Kidney Dis Karger Publ. 2016;17:1\u20139. \n                    https:\/\/doi.org\/10.1159\/000452880\n                    \n                  .","journal-title":"Kidney Dis Karger Publ"},{"issue":"12","key":"1591_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/toxins8120369","volume":"8","author":"P Kuczera","year":"2016","unstructured":"Kuczera P, Adamczak M, Wiecek A. Fibroblast growth factor-23\u2014a potential uremic toxin. Toxins (Basel). 2016;8(12):369. \n                    https:\/\/doi.org\/10.3390\/toxins8120369\n                    \n                  .","journal-title":"Toxins (Basel)"},{"key":"1591_CR17","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Guti\u00e9rrez OM, Scialla J, Xie H, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79:1370\u20138.","journal-title":"Kidney Int"},{"issue":"1","key":"1591_CR18","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","volume":"75","author":"Ming Chang Hu","year":"2013","unstructured":"Hu MC, Shiizaki K, Kuro-O M, Moe OW. Fibroblast growth factor 23 and klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol. 2013. p.\u00a0503\u201333. \n                    https:\/\/doi.org\/10.1146\/annurev-physiol-030212-183727\n                    \n                  .","journal-title":"Annual Review of Physiology"},{"key":"1591_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/bs.vh.2016.02.007","volume-title":"Klotho","author":"J.A. Neyra","year":"2016","unstructured":"Neyra JA, Hu MC. \u03b1Klotho and chronic kidney disease. Vitam Horm. 2016. p.\u00a0257\u2013310. \n                    https:\/\/doi.org\/10.1016\/bs.vh.2016.02.007\n                    \n                  ."},{"key":"1591_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45\u201351.","journal-title":"Nature"},{"key":"1591_CR21","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1112766","volume":"309","author":"H Kurosu","year":"2005","unstructured":"Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, et al. Suppression of aging in mice by the Hormone Klotho. Science. 2005;309:1829\u201333.","journal-title":"Science"},{"key":"1591_CR22","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med Massachusetts Med Soc. 2004;351:1296\u2013305.","journal-title":"N Engl J Med Massachusetts Med Soc"},{"key":"1591_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/978-1-4614-0887-1_9","volume":"728","author":"MC Hu","year":"2012","unstructured":"Hu MC, Kuro-o M, Moe OW. Secreted Klotho And Chronic Kidney disease. Adv Exp Med Biol. 2012;728:126\u201357. \n                    https:\/\/doi.org\/10.1007\/978-1-4614-0887-1_9\n                    \n                  .","journal-title":"Adv Exp Med Biol"},{"key":"1591_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ki.2013.149","volume":"84","author":"M-C Hu","year":"2013","unstructured":"Hu M-C, Shi M, Cho HJ, Zhang J, Pavlenco A, Liu S, et al. The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection. Kidney Int. 2013;84:468\u201381.","journal-title":"Kidney Int"},{"key":"1591_CR25","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1681\/ASN.2010121251","volume":"22","author":"MH Borst De","year":"2011","unstructured":"De Borst MH, Vervloet MG, Ter Wee PM, Navis G. Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol. 2011;22:1603\u20139. \n                    https:\/\/doi.org\/10.1681\/ASN.2010121251\n                    \n                  .","journal-title":"J Am Soc Nephrol"},{"key":"1591_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht151","author":"G Mancia","year":"2013","unstructured":"Mancia G, De Backer G, Dominiczak A, et al. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/eht151\n                    \n                  .","journal-title":"Eur Heart J"},{"issue":"1","key":"1591_CR27","first-page":"33","volume":"13","author":"VM Ermolenko","year":"2011","unstructured":"Ermolenko VM, Volgina GV, Dobronravov VA, et al. National recommendations on mineral and bone disorders in chronic kidney disease. Russian Dialysis Society (May 2010).Nephrologia I Dialis. 2011;13(1):33\u201351.","journal-title":"Nephrologia I Dialis"},{"issue":"7","key":"1591_CR28","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1681\/ASN.2015040369","volume":"27","author":"L Garneata","year":"2016","unstructured":"Garneata L, Stancu A, Dragomir D, Stefan G, Mircescu G. Ketoanalogue-supplemented vegetarian very low\u2013protein diet and CKD progression. J Am Soc Nephrol. 2016;27(7):2164\u201376. \n                    https:\/\/doi.org\/10.1681\/ASN.2015040369\n                    \n                  .","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"1591_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/jcsm.12264","volume":"9","author":"RCM,AS-F Kovesdy","year":"2018","unstructured":"Kovesdy RCM,AS-F, Kalantar-Zadeh CP. K. Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials. J Cachexia Sarcopenia Muscle. 2018;9(2):235\u201345. \n                    https:\/\/doi.org\/10.1002\/jcsm.12264\n                    \n                  .","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"1591_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.15690\/vramn581","volume":"71","author":"LY Milovanova","year":"2016","unstructured":"Milovanova LY, Mukhin NA, Kozlovskaya LV, Milovanov YS, Kiyakbaev GG, Rogova IV, et al. Decreased serum levels of klotho protein in chronic kidney disease patients: clinical importance. Vestn Ross Akad Meditsinskikh Nauk. 2016;71:288\u201396. \n                    https:\/\/doi.org\/10.15690\/vramn581\n                    \n                  .","journal-title":"Vestn Ross Akad Meditsinskikh Nauk"},{"key":"1591_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.01.017","author":"JA Neyra","year":"2017","unstructured":"Neyra JA, Hu MC. Potential application of klotho in human chronic kidney disease. Bone. 2017. \n                    https:\/\/doi.org\/10.1016\/j.bone.2017.01.017\n                    \n                  .","journal-title":"Bone"},{"key":"1591_CR32","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/ncomms2240","volume":"3","author":"J Xie","year":"2012","unstructured":"Xie J, Cha S-K, An S-W, Kuro-o M, Birnbaumer L, Huang C-L. Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart. Nat Commun. 2012;3:1238. \n                    https:\/\/doi.org\/10.1038\/ncomms2240\n                    \n                  .","journal-title":"Nat Commun"},{"issue":"1","key":"1591_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000356118","volume":"3","author":"MM NasrAllah","year":"2013","unstructured":"NasrAllah MM, El-Shehaby AR, Osman NA, Fayad T, Nassef A, Salem MM, et al. The association between fibroblast growth factor-23 and vascular calcification is mitigated by inflammation markers. Nephron Extra. 2013;3(1):106\u201312. \n                    https:\/\/doi.org\/10.1159\/000356118\n                    \n                  .","journal-title":"Nephron Extra"},{"key":"1591_CR34","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/hh2401.101070","volume":"89","author":"SA Steitz","year":"2001","unstructured":"Steitz SA, Speer MY, Curinga G, Yang H-Y, Haynes P, Aebersold R, et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001;89:1147\u201354.","journal-title":"Circ Res"},{"key":"1591_CR35","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/labinvest.2015.153","volume":"96","author":"D Zhou","year":"2016","unstructured":"Zhou D, Tan RJ, Fu H, Liu Y. Wnt\/[beta]-catenin signaling in kidney injury and repair: a double-edged sword. Lab Invest. 2016;96:156\u201367. \n                    https:\/\/doi.org\/10.1038\/labinvest.2015.153\n                    \n                  .","journal-title":"Lab Invest"},{"key":"1591_CR36","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1681\/ASN.2013080818","volume":"25","author":"Y Fang","year":"2014","unstructured":"Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, Register TC, et al. CKD-induced wingless\/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder. J Am Soc Nephrol. 2014;25:1760\u201373. \n                    https:\/\/doi.org\/10.1681\/ASN.2013080818\n                    \n                  .","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-018-1591-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1591-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-018-1591-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T19:28:16Z","timestamp":1560194896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-018-1591-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1591"],"URL":"https:\/\/doi.org\/10.1007\/s10157-018-1591-1","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]},"assertion":[{"value":"16 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study was approved by the Institutional Review Board of the Sechenov First Moscow State Medical University (Protocol No. 06\u201314, 16.06.2014). All the patients provided written informed consent. All the described procedures were performed in accordance with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}